At a glance
ClinicalIndex Comparison RecordN/ACompleted· 346 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Clinical Utility of the Congo-Red Dot Test for Diagnosis and Early Prediction of Preeclampsia During Pregnancy
In Brief
An observational study for Preeclampsia. Completed, enrolled 346 participants across 1 site.
Detailed Summary
The aim of the study is to validate in a prospective fashion the value of the Congo-Red Dot (CRD) test for diagnosis of preeclampsia. The working hypothesis is that in pregnancies complicated by preeclampsia, will display urine congophilia and have a positive CRD test.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPreeclampsia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
First PostedMay 2015
Primary CompletionJul 2018
Study CompletionAug 2018
TodayJul 2026
First PostedMay 28, 2015
Enrollment StartAug 1, 2014
Primary CompletionJul 1, 2018
Study CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 11.1 years ago